Literature DB >> 17439761

Evidence and controversies in the use of post-mastectomy radiation.

Shaneli A Fernando1, Stephen B Edge.   

Abstract

Radiation after mastectomy is recommended for women with positive nodes, larger tumors, or positive margins. In addition to its role in reducing the risk for locoregional recurrence, it has an additive effect to the survival benefit seen with adjuvant systemic therapy. This article reviews the role of post-mastectomy radiation (PMRT) based on the recommendations in the 2007 NCCN Breast Cancer Clinical Practice Guidelines in Oncology and addresses the risk factors for recurrence after mastectomy. The data supporting both improvement in locoregional failure and survival are reviewed in detail. This article also discusses controversial areas in PMRT, including regional nodal radiation in women with 1 to 3 positive lymph nodes, PMRT in node-negative women with large tumors, and inclusion of internal mammary nodes. The final section discusses radiation field design and potential complications.

Entities:  

Mesh:

Year:  2007        PMID: 17439761     DOI: 10.6004/jnccn.2007.0028

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  4 in total

1.  Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

Authors:  R Kreienberg; U-S Albert; M Follmann; I B Kopp; T Kühn; A Wöckel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-06       Impact factor: 2.915

2.  Predicting the risk of secondary lung malignancies associated with whole-breast radiation therapy.

Authors:  John Ng; Igor Shuryak; Yanguang Xu; K S Clifford Chao; David J Brenner; Ryan J Burri
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-13       Impact factor: 7.038

3.  DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer.

Authors:  Frederik Wenz; Elena Sperk; Wilfried Budach; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Marc D Piroth; Marie-Luise Sautter-Bihl; Felix Sedlmayer; Rainer Souchon; Christoph Fussl; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2014-08       Impact factor: 3.621

4.  Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.

Authors:  Laura S Dominici; Elizabeth A Mittendorf; Xumei Wang; Jun Liu; Henry M Kuerer; Kelly K Hunt; Abenaa Brewster; Gildy V Babiera; Thomas A Buchholz; Funda Meric-Bernstam; Isabelle Bedrosian
Journal:  Breast Cancer Res       Date:  2012-05-23       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.